Literature DB >> 7554031

Apoptosis, cancer and the p53 tumour suppressor gene.

J M Lee1, A Bernstein.   

Abstract

One of the most commonly detected abnormalities in human cancer is mutation of the p53 tumour suppressor gene. Intrinsic to the function of p53 is its ability to induce apoptotic cell death and to cause cell cycle arrest. Moreover, p53 plays an important role in controlling the cellular response to DNA damaging agents such as ionizing radiation and cancer chemotherapeutic drugs. Loss of p53 function causes increased resistance to radiation and chemotherapeutic agents, and there is increasing evidence that p53 mutational status is an important determinant of clinical outcome in cancer. This review will focus on recent data describing the biochemistry of p53 function, its role in mediating apoptosis and cell cycle arrest and in the control of tumour growth and death.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554031     DOI: 10.1007/bf00665797

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  111 in total

1.  Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.

Authors:  J Bargonetti; P N Friedman; S E Kern; B Vogelstein; C Prives
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

Review 2.  Mammalian G1 cyclins.

Authors:  C J Sherr
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

3.  DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways.

Authors:  W G Nelson; M B Kastan
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

4.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours.

Authors:  L A Donehower; M Harvey; B L Slagle; M J McArthur; C A Montgomery; J S Butel; A Bradley
Journal:  Nature       Date:  1992-03-19       Impact factor: 49.962

5.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.

Authors:  J R Bischoff; P N Friedman; D R Marshak; C Prives; D Beach
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

8.  Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.

Authors:  M L Smith; I T Chen; Q Zhan; I Bae; C Y Chen; T M Gilmer; M B Kastan; P M O'Connor; A J Fornace
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

9.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  24 in total

1.  Studies on the influence of DNA repair on radiosensitivity in prostate cell lines.

Authors:  Antonio M Serafin; John M Akudugu; Lothar Böhm
Journal:  Urol Res       Date:  2003-04-01

Review 2.  Apoptosis: molecular mechanisms and implications for cancer chemotherapy.

Authors:  H J Guchelaar; A Vermes; I Vermes; C Haanen
Journal:  Pharm World Sci       Date:  1997-06

Review 3.  [Significance of apoptotic processes in radiotherapy. I].

Authors:  M Abend; D van Beuningen
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

Review 4.  [Significance of apoptotic processes in radiotherapy. II].

Authors:  M Abend; D van Beuningen
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

5.  Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage.

Authors:  T G Paulson; A Almasan; L L Brody; G M Wahl
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Attenuation of macrophage apoptosis by the cAMP-signaling system.

Authors:  A von Knethen; B Brüne
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

7.  Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells.

Authors:  Hong-Bing Ma; Shan Huang; Xiao-Ran Yin; Yang Zhang; Zheng-Li Di
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

8.  Geminin functions downstream of p53 in K-ras-induced gene amplification of dihydrofolate reductase.

Authors:  Ling Shen; Takashi Nishioka; Jinjin Guo; Changyan Chen
Journal:  Cancer Res       Date:  2012-10-01       Impact factor: 12.701

9.  The Gfi-1 protooncoprotein represses Bax expression and inhibits T-cell death.

Authors:  H L Grimes; C B Gilks; T O Chan; S Porter; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

10.  Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis.

Authors:  N Ahmad; D K Feyes; R Agarwal; H Mukhtar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.